SCHEMBL6401713

SCHEMBL6401713

Nn1c(=O)[nH]c2ccc(O)cc2c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
CA12 O43570 4/20 0.49
CA9 Q16790 4/20 0.49
GAA P10253 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 2/20 0.48
GLA P06280 2/20 0.48
POLB P06746 1/20 0.47
CASP6 P55212 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MPO P05164 1/20 0.46
FEN1 P39748 1/20 0.45
ROCK2 O75116 1/20 0.44
CHEK1 O14757 3/20 0.42
WEE1 P30291 2/20 0.42
HSP90AA1 P07900 2/20 0.41
CDK5 Q00535 2/20 0.41
DYRK1A Q13627 2/20 0.41
CDK5R1 Q15078 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6400493 0.81 CA12 (0.68) ALDH1A1CA12CA9GAAMEN1
SCHEMBL10085593 0.79 ALDH1A1 (0.72) ALDH1A1CA12CA9GAAMEN1
SCHEMBL6401721 0.79 CA9 (0.66) ALDH1A1CA12CA9GAAMEN1
SCHEMBL6406367 0.76 GAA (0.74) ALDH1A1CA12CA9GAAMEN1
SCHEMBL3754362 0.74 ALDH1A1 (1.00) ALDH1A1CA12CA9GAAKDM4E
SCHEMBL6401448 0.71 MPO (0.70) ALDH1A1CA12CA9GAAMEN1
SCHEMBL6398048 0.71 ERCC1 (0.51) ALDH1A1CA12CA9GAAMPO
SCHEMBL23963929 0.71 GAA (0.81) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL4506198 0.70 ALDH1A1 (0.61) ALDH1A1CA12CA9GAAMEN1
SCHEMBL30545874 0.70 TDP1 (0.61) GAAMEN1KMT2APOLBCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 ALDH1A1 408/4885CA12 3099/4885CA9 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.